Per Lund‐Johansen

4.9k total citations · 1 hit paper
137 papers, 3.3k citations indexed

About

Per Lund‐Johansen is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine and Surgery. According to data from OpenAlex, Per Lund‐Johansen has authored 137 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Cardiology and Cardiovascular Medicine, 48 papers in Complementary and alternative medicine and 23 papers in Surgery. Recurrent topics in Per Lund‐Johansen's work include Blood Pressure and Hypertension Studies (84 papers), Heart Rate Variability and Autonomic Control (51 papers) and Cardiovascular and exercise physiology (48 papers). Per Lund‐Johansen is often cited by papers focused on Blood Pressure and Hypertension Studies (84 papers), Heart Rate Variability and Autonomic Control (51 papers) and Cardiovascular and exercise physiology (48 papers). Per Lund‐Johansen collaborates with scholars based in Norway, United States and Sweden. Per Lund‐Johansen's co-authors include Per Omvik, Sverre E. Kjeldsen, Thomas Hedner, Jan Otto Syvertsen, Jan Lanke, Bengt E. Karlberg, Björn Dahlöf, Ulf dé Fairé, Lars Lindholm and Lennart Hansson and has published in prestigious journals such as The Lancet, Kidney International and The American Journal of Medicine.

In The Last Decade

Per Lund‐Johansen

133 papers receiving 3.0k citations

Hit Papers

Randomised trial of effects of calcium antagonists compar... 2000 2026 2008 2017 2000 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study
    2000 650 citations Thomas Hedner, Per Lund‐Johansen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Per Lund‐Johansen Norway 27 2.4k 813 515 395 337 137 3.3k
Antoon Amery Belgium 31 1.8k 0.7× 412 0.5× 412 0.8× 442 1.1× 347 1.0× 103 3.1k
Robert Fagard Belgium 25 1.5k 0.6× 664 0.8× 284 0.6× 306 0.8× 248 0.7× 86 2.5k
Vincent DeQuattro United States 29 1.9k 0.8× 815 1.0× 452 0.9× 147 0.4× 325 1.0× 106 3.3k
R. Fagard Belgium 27 1.6k 0.7× 538 0.7× 310 0.6× 364 0.9× 312 0.9× 85 2.6k
GD Johnston United Kingdom 25 1.8k 0.7× 603 0.7× 409 0.8× 191 0.5× 611 1.8× 72 3.1k
A. Amery Belgium 36 3.0k 1.3× 999 1.2× 694 1.3× 569 1.4× 476 1.4× 201 5.1k
Ivar Eide Norway 29 1.3k 0.5× 624 0.8× 410 0.8× 206 0.5× 486 1.4× 144 2.8k
Lawrence R. Krakoff United States 32 3.0k 1.2× 1.1k 1.4× 869 1.7× 197 0.5× 384 1.1× 120 4.9k
Henry L. Elliott United Kingdom 33 1.6k 0.7× 697 0.9× 376 0.7× 138 0.3× 529 1.6× 132 3.2k
P S Sever United Kingdom 25 1.7k 0.7× 559 0.7× 453 0.9× 110 0.3× 335 1.0× 67 2.8k

Countries citing papers authored by Per Lund‐Johansen

Since Specialization
Citations

This map shows the geographic impact of Per Lund‐Johansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Lund‐Johansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Lund‐Johansen more than expected).

Fields of papers citing papers by Per Lund‐Johansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Lund‐Johansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Lund‐Johansen. The network helps show where Per Lund‐Johansen may publish in the future.

Co-authorship network of co-authors of Per Lund‐Johansen

This figure shows the co-authorship network connecting the top 25 collaborators of Per Lund‐Johansen. A scholar is included among the top collaborators of Per Lund‐Johansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Lund‐Johansen. Per Lund‐Johansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lund‐Johansen, Per & Roger Kirby. (2003). Effect of Doxazosin GITS on Blood Pressure in Hypertensive and Normotensive Patients: A Review of Hypertension and BPH Studies. Blood Pressure. 12(sup1). 5–13. 8 indexed citations
2.
Kjeldsen, Sverre E., Thomas Hedner, Jan Otto Syvertsen, et al.. (2002). Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study. Journal of Hypertension. 20(6). 1231–1237. 24 indexed citations
3.
Timmermann, Bernd, Ran Mo, Friedrich C. Luft, et al.. (1998). β-2 Adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. Kidney International. 53(6). 1455–1460. 122 indexed citations
4.
Gerdts, Eva, Einar Svarstad, Sylvi Aanderud, et al.. (1998). Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using captopril or doxazosin for 6 months☆. American Journal of Hypertension. 11(10). 1178–1187. 9 indexed citations
5.
Gerdts, Eva, Einar Svarstad, Ole L. Myking, Per Lund‐Johansen, & Per Omvik. (1996). Salt Sensitivity in Hypertensive Type-1 Diabetes Mellitus. Blood Pressure. 5(2). 78–85. 18 indexed citations
6.
7.
Lund‐Johansen, Per, Per Omvik, & William B. White. (1994). Measurement of long-term hemodynamic changes and the use of 24-hour blood pressure monitoring to evaluate treatment. The American Journal of Cardiology. 73(3). A44–A49. 4 indexed citations
8.
Lund‐Johansen, Per & Per Omvik. (1993). Cardiac Effects of ACE Inhibition. Journal of Cardiovascular Pharmacology. 22. S36–40. 5 indexed citations
9.
10.
Lund‐Johansen, Per. (1992). The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension.. PubMed. 38 Suppl 1. S78–86. 4 indexed citations
11.
Lund‐Johansen, Per. (1992). Hemodynamics of elevated blood pressure.. PubMed. 1. 14–5. 4 indexed citations
12.
Lund‐Johansen, Per & Per Omvik. (1992). Chronic haemodynamic effects of carvedilol in essential hypertension at rest and during exercise. European Heart Journal. 13(2). 281–286. 14 indexed citations
13.
Lund‐Johansen, Per. (1992). Treatment of hypertension in the elderly?What have we learned from the recent trials?. Cardiovascular Drugs and Therapy. 6(6). 571–573. 1 indexed citations
14.
15.
Omvik, Per & Per Lund‐Johansen. (1991). Acute haemodynamic effects of carvedilol in essential hypertension at rest and during exercise. European Heart Journal. 12(6). 736–740. 8 indexed citations
16.
Lund‐Johansen, Per. (1989). Central haemodynamics in essential hypertension at rest and during exercise: a 20-year follow-up study. Journal of Hypertension. 7(6). S52–55. 46 indexed citations
17.
Lund‐Johansen, Per. (1987). Clinical Use of Calcium Antagonists in Hypertension. Journal of Cardiovascular Pharmacology. 10. S29–34. 3 indexed citations
18.
Lund‐Johansen, Per. (1987). Hemodynamics in Hypertension at Rest and During Exercise. Journal of Cardiovascular Pharmacology. 10(Supplement). S1–S5. 3 indexed citations
19.
Lund‐Johansen, Per. (1987). Hemodynamics in Hypertension at Rest and During Exercise. Journal of Cardiovascular Pharmacology. 10. S2–S5. 4 indexed citations
20.
Lund‐Johansen, Per. (1986). Effects of antihypertensive therapy on the hemodynamics of hypertension: clinical implications.. PubMed. 8(4). 382–97. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antoon Amery Breakdown of academic impact, for papers by Robert Fagard Breakdown of academic impact, for papers by Vincent DeQuattro Breakdown of academic impact, for papers by R. Fagard Breakdown of academic impact, for papers by GD Johnston Breakdown of academic impact, for papers by A. Amery Breakdown of academic impact, for papers by Ivar Eide Breakdown of academic impact, for papers by Lawrence R. Krakoff Breakdown of academic impact, for papers by Henry L. Elliott Breakdown of academic impact, for papers by P S Sever
Rankless by CCL
2026